A case of signet ring cell gastric cancer showing no progression without treatment for a period of three years

Abstract

Gastric cancer is the second most common cause of mortality after lung cancer worldwide. Gastric cancer with the histological diagnosis of signet ring cell carcinoma is generally considered to have a poor prognosis. We present a patient diagnosed with early-stage signet ring cell gastric carcinoma three years ago who refused surgical treatment. The disease showed no marked progression endoscopically or radiologically during the follow-up period of three years. Histopathological diagnosis of signet ring cell gastric carcinoma should not be considered as an absolute indicator of poor prognosis.

Keywords

• Signet ring cell gastric carcinoma, prognosis, untreated

Tedavisiz üç yıllık takiplerinde belirgin progresyon göstermeyen taşlı yüzük hücreli mide kanseri olgusu

Öz

Mide kanseri, dünyada mortaliteye neden olan en sık ikinci kanserdir. Taşlı yüzük hücreli mide kanserinin genel olarak kötü prognoza sahip olduğu bildirilmektedir. Bu vaka sunumunda 3 yıllık takibe rağmen çok hızlı progresyon göstermeyen taşlı yüzük hücreli mide kanseri sunulmuştur. Hastanın cerrahi tedaviyi kabul etmemesi nedeniyle üç yıl süreyle takip edilmesi mümkün olmuştur. Bu olguda radyolojik ve endoskopik incelemelerde üç yıllık takibe reğmen yayılım veya tümör çapında belirgin artış saptanmamıştır.

Anahtar Kelimeler

• Taşlı yüzük hücreli mide karsinomu, prognoz

Kaynakça

1. Neuguet AI, Hayek M, Howe G. Epidemiology of gastric cancer. Semin Oncol 1996; 23: 281-91.
2. Houghton JM, Wang TC. Tumors of the stomach. In: Feldman M, Fried- man L, Brandt L, Gastrointestinal and Liver Disease. 8thedition. Sanfran- cisco; Saunders Elsevier, 2006; 1139-61.
3. Yokota T, Kunii Y, Teshima S, et al. Signet ring cell carcinoma of the sto- mach: a cilinicopathological comparison with the other histological types. Tohoku J Exp Med 1998; 186: 121-30.
4. Theuer CP, Nastanski F, Brewster WR, et al. Signet ring cell histology is associated with unique clinical features but does not affect gastric cancer survival. Am Surg 1999; 65: 915-21.
5. Kim DY, Park YK, Joo JK, et al. Clinocopathological characteristic of sig- net ring cell carcinoma of the stomach. ANZ J Surg 2004; 74: 1060-4.
6. Li C, Kim S, Lai JF, et al. Advanced gastric carcinoma with signet ring cell histology. Oncology 2007; 72: 64-8.
7. Lazar D, Taban S, Sporea I, et al. Gastric cancer: correlation between ci- linicopathological factors and survival of patients. II. Rom J Morphol Embryol 2009; 50: 185-94.
8. Park JM, Jang YJ, Kim JH, et al. Gastric cancer histology: Clinicopatho- logic charateristics and prognostic value. J Surg Oncol 2008; 98: 520-5.